Is Ozempic Better Than Mounjaro for Weight Loss?

Last reviewed: June 28, 2026

Last updated: June 28, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Ozempic (semaglutide) and Mounjaro (tirzepatide) have transformed weight loss treatment, but they work through different mechanisms and deliver different outcomes. Clinical data shows tirzepatide produces approximately 20% body weight reduction compared to semaglutide's 13% reduction in head-to-head comparisons. PlexusDx provides access to both options through licensed compounding pharmacies, helping patients choose the right medication for their metabolic profile.

How Semaglutide and Tirzepatide Target Weight Loss Differently

Semaglutide activates the GLP-1 receptor, signaling fullness to the brain and slowing stomach emptying. This single-pathway approach reduces appetite and calorie intake by suppressing hunger hormones and increasing satiety signaling. The medication has been used for diabetes since 2008, offering a long safety track record in weight management applications.

Tirzepatide activates both GLP-1 and GIP receptors, creating a dual-hormone effect that targets appetite through two distinct metabolic pathways. By engaging the glucose-dependent insulinotropic peptide (GIP) system alongside GLP-1 signaling, tirzepatide amplifies feelings of fullness and metabolic regulation. This dual-receptor activation explains why tirzepatide consistently produces greater weight loss in clinical studies compared to single-receptor medications.

Clinical Trial Results: Weight Loss Comparison Between Medications

The STEP trials evaluating semaglutide demonstrated average weight loss of 10-15% over 68 weeks at maximum doses. Participants receiving semaglutide 2.4 mg weekly lost approximately 13% of their baseline body weight, with significant improvements in blood sugar control and cardiovascular risk factors. These results established semaglutide as an effective option for individuals with obesity or overweight with weight-related conditions.

Tirzepatide trials (SUMO series) showed participants lost 20-22% of baseline body weight at the highest dose over 72 weeks. Direct comparisons revealed tirzepatide produced significantly greater weight loss than semaglutide at equivalent timepoints, with some patients achieving results previously associated only with bariatric surgery. The superior efficacy comes from tirzepatide's ability to suppress appetite through two independent hormonal pathways rather than one.

Side Effects and Tolerability: What to Expect From Each Medication

Both medications cause gastrointestinal side effects including nausea, vomiting, and constipation, particularly during dose escalation. Semaglutide users typically report mild to moderate nausea that decreases within 2-3 weeks as the body adapts. Serious adverse events remain rare, though pancreatitis and gallbladder complications have been reported in post-marketing surveillance, affecting less than 1% of users.

Tirzepatide produces similar GI side effects but at slightly higher frequency and intensity, especially in the first month of treatment. Patients starting tirzepatide should expect potential nausea, diarrhea, or constipation requiring dietary adjustments. Both medications require careful dose titration starting at lower amounts to allow the body to adjust before gradually increasing, which PlexusDx prescribers manage through personalized dosing schedules based on individual tolerability.

Personalized Choice: Finding Your Optimal GLP-1 Medication at PlexusDx

PlexusDx offers both compounded semaglutide injections starting at $149/month and compounded tirzepatide injections starting at $249/month through licensed 503A pharmacies in all 50 states. Because pricing remains flat per compound regardless of dose escalation, patients can increase their medication strength as needed without worrying about rising costs. This transparent pricing model removes barriers to finding the right dose for individual metabolism and weight loss goals.

The Precision Peptide Genetic Test available through PlexusDx examines variants in four key genetic pathways including GLP1R rs6923761, GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 to predict medication responsiveness. Patients with specific genetic patterns may experience better outcomes with dual-receptor activation through tirzepatide compared to single-receptor semaglutide. PlexusDx prescribers combine genetic insights with clinical response to guide dosing decisions and medication selection within the first month of treatment.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection starts at $249/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Will I lose more weight on Mounjaro (tirzepatide) than Ozempic (semaglutide)?

Clinical trials show tirzepatide produces approximately 20% body weight loss versus 13% for semaglutide, making tirzepatide more effective for most patients. However, individual results vary based on genetics, lifestyle, and how your body responds to single versus dual-receptor activation. PlexusDx can help determine which medication aligns better with your metabolic profile through genetic testing and clinical monitoring.

How does the dual-receptor mechanism of tirzepatide work compared to semaglutide?

Tirzepatide activates both GLP-1 and GIP receptors to suppress appetite through two independent hormonal pathways, while semaglutide activates only the GLP-1 receptor. This dual activation creates stronger satiety signals and greater metabolic improvements, explaining tirzepatide's superior weight loss outcomes in head-to-head studies. The combination of two receptors essentially amplifies the appetite-suppression effect.

Does PlexusDx charge more for higher doses of tirzepatide or semaglutide?

No. PlexusDx prices compounded tirzepatide injections at a flat $249/month and semaglutide injections at $149/month regardless of your dose strength. Your dose may need to go up as your body adjusts, but your price won't change, making it affordable to find your optimal therapeutic level.

Are compounded versions of Ozempic and Mounjaro safe?

PlexusDx compounded medications come from licensed 503A compounding pharmacies, which operate under strict FDA oversight and state pharmacy board regulations. These facilities maintain identical sterility and potency standards as brand-name manufacturers. While compounded medications are not FDA-approved products, they're prepared by regulated pharmacies using FDA-approved active pharmaceutical ingredients.

Can genetic testing help me decide between semaglutide and tirzepatide?

Yes. PlexusDx's Precision Peptide Genetic Test examines variants in GLP1R, GIPR, FTO, and MC4R genes that influence how your body responds to these medications. Certain genetic patterns predict better outcomes with dual-receptor tirzepatide, while others may respond equally well to single-receptor semaglutide. This personalized insight guides medication selection to maximize your weight loss potential.

Related Reading

• Ozempic For Weight Loss 2
• Average Weight Loss On Ozempic
• Mounjaro For Weight Loss 2
• Weight Loss Drugs Like Ozempic

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.